Loading...
•
Mar 31, 2022
IRadimed Q1 2022 Earnings Report
Reported strong first quarter results with increased revenue and earnings.
Key Takeaways
iRadimed Corporation announced strong first-quarter results, with revenue increasing to $12.3 million compared to $9.2 million in the first quarter of 2021. Net income also rose to $2.5 million, or $0.20 per diluted share, compared to $1.4 million, or $0.11 per diluted share in the prior year. The company increased its full-year outlook, expecting revenue of $52.5 million to $53.2 million and non-GAAP earnings per share of $0.96 to $1.03.
Revenue increased to $12.3 million compared to $9.2 million for the first quarter 2021.
Net income was $2.5 million, or $0.20 per diluted share, compared to $1.4 million, or $0.11 per diluted share for the first quarter 2021.
Non-GAAP net income was $2.8 million, or $0.22 per diluted share.
Company increased its full year 2022 financial guidance.
Forward Guidance
For the second quarter 2022, the Company expects to report revenue of $12.5 million to $12.7 million, GAAP diluted earnings per share of $0.21 to $0.23, and non-GAAP diluted earnings per share of $0.23 to $0.25. The Company increased its full year 2022 financial guidance and now expects to report revenue of $52.5 million to $53.2 million, GAAP diluted earnings per share of $0.89 to $0.95, and non-GAAP diluted earnings per share of $0.96 to $1.03.
Positive Outlook
- Expects revenue of $12.5 million to $12.7 million for Q2 2022.
- Expects GAAP diluted earnings per share of $0.21 to $0.23 for Q2 2022.
- Expects non-GAAP diluted earnings per share of $0.23 to $0.25 for Q2 2022.
- Increased full year 2022 revenue guidance to $52.5 million to $53.2 million.
- Increased full year 2022 non-GAAP diluted earnings per share guidance to $0.96 to $1.03.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...